Safety and Pharmacokinetics of Multiple Rising Oral Doses of BI 224436 in Healthy Male Volunteers.
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To investigate the safety and pharmacokinetic of BI 224436 in healthy male volunteers
following oral administration of repeated doses for 10 days within 8 dosing regimens.